Compounds > alendronate

alendronate and clodronic acid

alendronate has been researched along with clodronic acid in 81 studies

Research

Studies (81)

TimeframeStudies, this research(%)All Research%
pre-19903 (3.70)18.7374
1990's26 (32.10)18.2507
2000's31 (38.27)29.6817
2010's18 (22.22)24.3611
2020's3 (3.70)2.80

Authors

AuthorsStudies
Lecouvey, M; Monteil, M; Puljula, E; Turhanen, P; Vepsäläinen, J; Weisell, J1
Almeida Paz, FA; Barbosa, JS; Braga, SS1
Bonjour, JP; Buchs, B; Rizzoli, R1
Fleisch, H; Janner, M; Mühlbauer, RC1
Bauss, F; Bosies, E; Fleisch, H; Janner, M; Mühlbauer, RC; Schenk, R; Strein, K1
Warrell, RP1
Adami, S; Garavelli, S; Guarrera, G; Lo Cascio, V; Montesanti, F; Rosini, S; Salvagno, G1
Ascari, E; Attardo-Parrinello, G; Crema, F; Fiorentini, ML; Merlini, G; Pavesi, F1
Bettschen-Camin, L; Felix, R; Fleisch, H; Stronski, SA; Trechsel, U; Wetterwald, A1
Alfano, FS; Basini, G; Campanini, C; Fantuzzi, M; Gatti, C; Girasole, G; Passeri, M; Pedrazzoni, M1
Koyano, H; Schimizu, T; Shishiba, Y1
Bell, C; Brooks, MA; Chamberlin, SD; Forsyth, RJ; Ip, DP; Tsai, EW1
Aloisi, R; Benetti, D; Fantozzi, R; Mian, M; Rosini, S1
Collin, P; Fleisch, H; Guenther, HL; Martin, TJ; Sahni, M1
Hirvonen, MR; Makkonen, N; Mönkkönen, J; Savolainen, K; Teräväinen, T1
Antic, VN; Fleisch, H; Mühlbauer, RC1
Kawano, S; Moriyama, H; Nagai, H; Naito, M; Takatsuka, H; Takei, Y; Umezu, H; Yamamoto, T; Zhu, H1
Licata, AA1
Body, JJ; Coleman, RE; Piccart, M1
Adachi, H; Hirafuji, M; Igarashi, K; Mitani, H; Shinoda, H1
Fleisch, HA1
Blackburn, GM; Frith, JC; Mönkkönen, J; Rogers, MJ; Russell, RG1
Adami, S1
Girasole, G; Giuliani, N; Passeri, G; Pedrazzoni, M1
Coxon, FP; Graham, R; Hughes, DE; Luckman, SP; Rogers, MJ; Russell, G1
Knowles, S; Phillips, E; Shear, NH; Weber, E1
Gennari, C; Reginster, JY1
Fisher, JE; Halasy, JM; Hughes, DE; Luckman, SP; Masarachia, PJ; Reszka, AA; Rodan, GA; Rogers, MJ; Russell, RG; Wesolowski, G1
Azhayeva, E; Frith, JC; Makkonen, N; Mönkkönen, J; Rogers, MJ; Salminen, A; Urtti, A1
Halasy-Nagy, JM; Masarachia, PJ; Reszka, AA; Rodan, GA1
Fallon, JJ; Goldstein, MF; Harning, R1
Berenson, J; Hortobagyi, G; Lipton, A; Major, PP1
del Puente, A; Ferrara, G; Itto, E; Oriente, P; Scognamiglio, A1
Watts, NB1
Auriola, S; Frith, JC; Mönkkönen, H; Mönkkönen, J; Rogers, MJ1
Aspenberg, P; Astrand, J1
Härkönen, PL; Lakkakorpi, PT; Väänänen, HK; Virtanen, SS1
Crisafulli, A; Di Pietro, C; Frisina, N; Gaudio, A; Lasco, A; Meo, A; Morabito, N1
Frith, JC; Rogers, MJ1
Epstein, M; Joshua, F; Major, G1
Endo, Y; Funayama, H; Mayanagi, H; Monma, Y1
Aoyagi, S; Itoh, F; Kogo, H; Kojima, M; Kusama, H1
Hershman, D; Narayanan, R1
Boos, J; Lanvers-Kaminsky, C; Vorotnjak, M1
Abrahamsen, B; Brixen, KT; Kassem, MS; Mosekilde, L1
Endo, Y; Funayama, H; Mayanagi, H; Monma, Y; Ohsako, M; Sugawara, S1
Azzarello, G; Balducci, E; Crepaldi, G; Dalle Carbonare, L; Giannini, S; Realdi, G; Valenti, MT; Vinante, O1
Conroy, M; Cree, IA; Fernando, A; Knight, LA; Kurbacher, CM; Polak, M1
Deng, X; Endo, Y; Funayama, H; Kuroishi, T; Sasano, T; Sugawara, S; Yu, Z1
Deng, X; Endo, Y; Funayama, H; Iwakura, Y; Sasano, T; Shoji, N; Sugawara, S; Yu, Z1
Coxon, FP; Crockett, JC; Rogers, MJ; Thompson, K1
Franke, HR; Verdijk, R; Vermes, I; Wolbers, F1
Langdahl, B; Mosekilde, L; Vestergaard, P1
Deng, X; Endo, Y; Funayama, H; Sasano, T; Sugawara, S; Yamaguchi, K; Yu, Z1
Azzarello, G; Balducci, E; Bertoldo, F; Dalle Carbonare, L; Fracalossi, A; Lo Cascio, V; Valenti, MT; Vinante, O1
Pritchard, KI1
Dulea, C; Gherase, A; Savu, SR; Silvestro, L; Tarcomnicu, I1
Honda, S; Imai, H; Nagai, T; Negi, A1
Alva, D; Cesareo, R; Contini, S; De Rosa, B; Iozzino, M; Lauria, A; Mallardo, L; Napolitano, C; Orsini, A; Reda, G1
Márton, I; Redl, P; Udvardy, E1
Deng, X; Endo, Y; Kiyoura, Y; Tamai, R1
Rogers, HL; Rogers, MJ; Sutherland, KA; Tosh, D1
Prutthiwanasan, B; Suntornsuk, L1
Endo, Y; Nagai, Y; Oizumi, T; Okada, S; Shikama, Y; Shimauchi, H; Sugawara, S1
Lamprecht, A; Ulbrich, W1
Aro, HT; Heervä, E; Peltonen, J; Peltonen, S; Svedström, E; Väänänen, K1
Carson, DA; Cho, JS; Corr, M; Crain, B; Hayashi, T; Miller, LS; Norton, JT1
Bianco, AM; Crovella, S; Decorti, G; Marcuzzi, A; Monasta, L; Piscianz, E; Vuch, J; Zanin, V1
Hayden, RS; Kaplan, DL; Vollrath, M1
Brennan, PA; Jenei, V; McLeod, NM; Moutasim, KA; Thomas, G1
Bouxsein, ML; Brooks, DJ; Demay, MB; Louis, L; Zhu, ED1
De Luna-Bertos, E; García-Martínez, O; Manzano-Moreno, FJ; Ramos-Torrecillas, J; Ruiz, C1
Bhardwaj, A; Osunkwo, I; Sinha, NK; Swe, KM1
Mészaros, Á; Veszelyné Kotán, E2
Danenberg, HD; Golomb, G; Grad, E; Gutman, D; Nordling-David, MM; Zolotarevsky, K1
Al-Nawas, B; Jung, J; Kwon, YD; Pabst, AM; Park, JS; Righesso, L; Walter, C1
García-Martínez, O; Illescas-Montes, R; Manzano-Moreno, FJ; Melguizo-Rodríguez, L; Ramos-Torrecillas, J; Ruiz, C1
Bond, AM; Flynn, D; Keyes, TE; MacConnell, N; Maher, S; McDaid, D; Ramadurai, S; Sarangi, NK1
Adams, A; Heidenreich, A; Jakob, T; Kuhr, K; Macherey, S; Monsef, I; Skoetz, N; Tesfamariam, YM1
Bhardwaj, A; Sinha, NK; Swe, KMM1

Reviews

19 review(s) available for alendronate and clodronic acid

ArticleYear
Bisphosphonates, Old Friends of Bones and New Trends in Clinics.
    Journal of medicinal chemistry, 2021, 02-11, Volume: 64, Issue:3

    Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Diphosphonates; Drug Compounding; Drug Delivery Systems; Humans

2021
Hypercalcemia and bone metastases in breast cancer.
    Current opinion in oncology, 1990, Volume: 2, Issue:6

    Topics: Alendronate; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Hypercalcemia; Neoplasm Proteins; Pamidronate; Parathyroid Hormone-Related Protein; Proteins; Transforming Growth Factors

1990
Bisphosphonate therapy.
    The American journal of the medical sciences, 1997, Volume: 313, Issue:1

    Topics: Alendronate; Animals; Bone Density; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Osteoclasts; Osteoporosis; Osteoporosis, Postmenopausal; Pamidronate; Risedronic Acid

1997
Use of bisphosphonates in cancer patients.
    Cancer treatment reviews, 1996, Volume: 22, Issue:4

    Topics: Alendronate; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Multiple Myeloma; Osteolysis; Pain; Pamidronate; Structure-Activity Relationship

1996
Bisphosphonates: preclinical aspects and use in osteoporosis.
    Annals of medicine, 1997, Volume: 29, Issue:1

    Topics: Alendronate; Animals; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Osteoporosis; Pamidronate

1997
Bisphosphonates in prostate carcinoma.
    Cancer, 1997, Oct-15, Volume: 80, Issue:8 Suppl

    Topics: Alendronate; Biomarkers; Bone Diseases; Bone Neoplasms; Bone Resorption; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Male; Neoplasm Invasiveness; Osteoclasts; Pain; Prostatic Neoplasms

1997
Bisphosphonates and osteoporosis treatment in Italy.
    Aging (Milan, Italy), 1998, Volume: 10, Issue:4

    Topics: Aged; Alendronate; Bone and Bones; Bone Density; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Italy; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Safety

1998
Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease.
    Chest, 1999, Volume: 116, Issue:6

    Topics: Administration, Inhalation; Administration, Oral; Adult; Alendronate; Asthma; Bone Density; Bone Remodeling; Calcitonin; Clodronic Acid; Etidronic Acid; Fluorides; Glucocorticoids; Hormone Replacement Therapy; Humans; Lung Diseases, Obstructive; Osteoporosis; Prednisone; Time Factors

1999
Oral bisphosphonates: A review of clinical use in patients with bone metastases.
    Cancer, 2000, Jan-01, Volume: 88, Issue:1

    Topics: Alendronate; Biological Availability; Bone Density; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Clodronic Acid; Diphosphonates; Double-Blind Method; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Male; Multiple Myeloma; Pamidronate; Prostatic Neoplasms; Pyridines; Randomized Controlled Trials as Topic; Risedronic Acid; Zoledronic Acid

2000
Treatment of osteoporosis with bisphosphonates.
    Rheumatic diseases clinics of North America, 2001, Volume: 27, Issue:1

    Topics: Aged; Alendronate; Bone and Bones; Bone Density; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Pamidronate; Risedronic Acid

2001
Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer.
    Current oncology reports, 2004, Volume: 6, Issue:4

    Topics: Absorptiometry, Photon; Alendronate; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Breast Neoplasms; Calcitonin; Calcium; Clodronic Acid; Diphosphonates; Drug Therapy, Combination; Estrogens; Etidronic Acid; Female; Humans; Imidazoles; Male; Osteoporosis; Prostatic Neoplasms; Quality of Life; Risedronic Acid; Risk Factors; Treatment Outcome; Vitamin D; Zoledronic Acid

2004
[Pharmacological treatment of osteitis deformans (Paget's bone disease)].
    Ugeskrift for laeger, 2005, Feb-28, Volume: 167, Issue:9

    Topics: Alendronate; Analgesics, Non-Narcotic; Antimetabolites; Calcitonin; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate; Radionuclide Imaging; Risedronic Acid

2005
Fracture prevention in postmenopausal women.
    Clinical evidence, 2006, Issue:15

    Topics: Aged; Alendronate; Bone Density Conservation Agents; Calcitonin; Calcium; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Spontaneous; Hormone Replacement Therapy; Humans; Ibandronic Acid; Osteoporosis, Postmenopausal; Pamidronate; Parathyroid Hormone; Risedronic Acid; Selective Estrogen Receptor Modulators; Vitamin D

2006
Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures.
    Minerva endocrinologica, 2007, Volume: 32, Issue:4

    Topics: Alendronate; Bone Density Conservation Agents; Bone Resorption; Calcitonin; Clodronic Acid; Diphosphonates; Etidronic Acid; Evidence-Based Medicine; Female; Fractures, Bone; Humans; Ibandronic Acid; Organometallic Compounds; Osteoporosis, Postmenopausal; Risedronic Acid; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Vitamin D

2007
[Osteonecrosis of the jaw developing during bisphosphonate treatment].
    Magyar onkologia, 2008, Volume: 52, Issue:1

    Topics: Alendronate; Anti-Infective Agents; Bone Density Conservation Agents; Bone Neoplasms; Bone Remodeling; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Mandible; Mandibular Diseases; Oral Hygiene; Oral Surgical Procedures; Osteonecrosis; Patient Care Team; Referral and Consultation; Zoledronic Acid

2008
Treatment for osteoporosis in people with ß-thalassaemia.
    The Cochrane database of systematic reviews, 2016, Mar-10, Volume: 3

    Topics: Adolescent; Adult; Alendronate; beta-Thalassemia; Bone Density; Bone Density Conservation Agents; Child; Clodronic Acid; Diphosphonates; Female; Femur Neck; Humans; Male; Middle Aged; Osteoporosis; Randomized Controlled Trials as Topic; Zinc Sulfate

2016
[Therapeutic practice of bisphosphonate use and related pharmaceutical issues I].
    Acta pharmaceutica Hungarica, 2016, Volume: 86, Issue:1

    Topics: Alendronate; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Neoplasms; Clodronic Acid; Diphosphonates; Fractures, Bone; Humans; Hungary; Ibandronic Acid; Imidazoles; Osteoporosis; Pamidronate; Risedronic Acid; Zoledronic Acid

2016
Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.
    The Cochrane database of systematic reviews, 2020, 12-03, Volume: 12

    Topics: Adult; Alendronate; Antineoplastic Agents, Hormonal; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Clodronic Acid; Denosumab; Diphosphonates; Etidronic Acid; Humans; Male; Network Meta-Analysis; Pamidronate; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Randomized Controlled Trials as Topic; RANK Ligand; Risedronic Acid; Zoledronic Acid

2020
Treatment for osteoporosis in people with beta-thalassaemia.
    The Cochrane database of systematic reviews, 2023, 05-09, Volume: 5

    Topics: Adult; Alendronate; beta-Thalassemia; Child; Clodronic Acid; Denosumab; Diphosphonates; Female; Fractures, Bone; Humans; Male; Middle Aged; Osteoporosis; Pamidronate

2023

Trials

6 trial(s) available for alendronate and clodronic acid

ArticleYear
Effect of a single infusion of alendronate in malignant hypercalcaemia: dose dependency and comparison with clodronate.
    International journal of cancer, 1992, Mar-12, Volume: 50, Issue:5

    Topics: Aged; Alendronate; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms

1992
Hypercalcemia and bone metastases in breast cancer.
    Current opinion in oncology, 1990, Volume: 2, Issue:6

    Topics: Alendronate; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Hypercalcemia; Neoplasm Proteins; Pamidronate; Parathyroid Hormone-Related Protein; Proteins; Transforming Growth Factors

1990
Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate.
    Archives of internal medicine, 1987, Volume: 147, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Alendronate; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Calcium; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Pain

1987
Intramuscular clodronate in nonresponders to oral alendronate therapy for osteoporosis.
    The Journal of rheumatology, 2000, Volume: 27, Issue:8

    Topics: Absorptiometry, Photon; Administration, Oral; Aged; Alendronate; Alkaline Phosphatase; Analgesics, Non-Narcotic; Bone Density; Case-Control Studies; Clodronic Acid; Female; Femur Neck; Humans; Injections, Intramuscular; Middle Aged; Osteoporosis, Postmenopausal; Treatment Outcome

2000
Bisphosphonates in the treatment of thalassemia-induced osteoporosis.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2002, Volume: 13, Issue:8

    Topics: Absorptiometry, Photon; Adolescent; Adult; Alendronate; Analysis of Variance; beta-Thalassemia; Biomarkers; Bone Density; Bone Remodeling; Clodronic Acid; Diphosphonates; Female; Humans; Male; Osteoporosis; Placebo Effect

2002
Bisphosphonate resistance in Paget's disease of bone.
    Arthritis and rheumatism, 2003, Volume: 48, Issue:8

    Topics: Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Anti-Inflammatory Agents; Clodronic Acid; Diphosphonates; Drug Resistance; Humans; Injections, Intravenous; Middle Aged; Osteitis Deformans; Pamidronate

2003

Other Studies

57 other study(ies) available for alendronate and clodronic acid

ArticleYear
Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial esters.
    ACS medicinal chemistry letters, 2015, Apr-09, Volume: 6, Issue:4

    Topics:

2015
Sodium EDTA enhances intestinal absorption of two bisphosphonates.
    Calcified tissue international, 1991, Volume: 49, Issue:4

    Topics: Administration, Oral; Alendronate; Analysis of Variance; Animals; Calcium; Clodronic Acid; Diphosphonates; Edetic Acid; Intestinal Absorption; Male; Rats; Rats, Inbred Strains

1991
BM 21.0955, a potent new bisphosphonate to inhibit bone resorption.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1991, Volume: 6, Issue:9

    Topics: Alendronate; Animals; Benzoates; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Etidronic Acid; Ibandronic Acid; Injections, Intravenous; Osteoclasts; Pamidronate; Rats; Retinoids; Risedronic Acid; Spectrophotometry, Atomic; Tetracycline; Thyroxine

1991
Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.
    Calcified tissue international, 1986, Volume: 39, Issue:4

    Topics: Alendronate; Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Drug Resistance; Humans; Hydroxyproline; Infusions, Intravenous; Osteitis Deformans

1986
Bisphosphonates inhibit 1,25-dihydroxyvitamin D3-induced increase of osteocalcin in plasma of rats in vivo and in culture medium of rat calvaria in vitro.
    Calcified tissue international, 1988, Volume: 42, Issue:4

    Topics: Alendronate; Animals; Calcitriol; Calcium-Binding Proteins; Clodronic Acid; Culture Techniques; Diphosphonates; DNA; Male; Osteoblasts; Osteocalcin; Proline; Rats; Rats, Inbred Strains; Skull

1988
Acute effects of bisphosphonates on new and traditional markers of bone resorption.
    Calcified tissue international, 1995, Volume: 57, Issue:1

    Topics: Acid Phosphatase; Aged; Aged, 80 and over; Alendronate; Amino Acids; Biomarkers; Bone and Bones; Bone Resorption; Clodronic Acid; Collagen; Collagen Type I; Diphosphonates; Female; Humans; Hydroxyproline; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Osteoporosis; Peptides; Time Factors

1995
The bisphosphonate dilemma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:4

    Topics: Alendronate; Bone and Bones; Bone Neoplasms; Clodronic Acid; Diphosphonates; False Negative Reactions; Female; Humans; Hypercalcemia; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Technetium Tc 99m Medronate

1995
Determination of bisphosphonate drugs in pharmaceutical dosage formulations by ion chromatography with indirect UV detection.
    Journal of pharmaceutical and biomedical analysis, 1994, Volume: 12, Issue:8

    Topics: Alendronate; Chromatography, Ion Exchange; Clodronic Acid; Diphosphonates; Etidronic Acid; Indicators and Reagents; Spectrophotometry, Ultraviolet

1994
Effects of bisphosphonate derivatives on macrophage function.
    Pharmacology, 1994, Volume: 49, Issue:5

    Topics: Alendronate; Animals; Bone Diseases; Clodronic Acid; Diphosphonates; Glucuronidase; Lysosomes; Macrophages, Peritoneal; Phagocytosis; Rats; Superoxides

1994
Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.
    The Journal of clinical investigation, 1993, Volume: 91, Issue:5

    Topics: Alendronate; Animals; Animals, Newborn; Bone Resorption; Cell Line; Cells, Cultured; Clodronic Acid; Culture Media, Conditioned; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Ibandronic Acid; Kinetics; Osteoblasts; Pamidronate; Parathyroid Hormone; Rats; Rats, Wistar; Time Factors

1993
Different effects of three bisphosphonates on nitric oxide production by RAW 264 macrophage-like cells in vitro.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:2

    Topics: Alendronate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Clodronic Acid; Diphosphonates; Female; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred BALB C; Nitric Oxide; Pamidronate

1996
Effect of bisphosphonates on the increase in bone resorption induced by a low calcium diet.
    Calcified tissue international, 1996, Volume: 58, Issue:6

    Topics: Alendronate; Animals; Bone Resorption; Calcium; Calcium, Dietary; Clodronic Acid; Diphosphonates; Disease Models, Animal; Homeostasis; Ibandronic Acid; Male; Rats; Rats, Wistar; Tetracycline

1996
Liposome-encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro.
    Journal of leukocyte biology, 1996, Volume: 60, Issue:3

    Topics: Alendronate; Animals; Apoptosis; Biotin; Clodronic Acid; DNA; DNA Nucleotidylexotransferase; Drug Carriers; Female; Gadolinium; Kupffer Cells; Liposomes; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Microscopy, Electron; Rats; Rats, Wistar; RNA; Uridine Triphosphate

1996
Effects of bisphosphonates on alkaline phosphatase activity, mineralization, and prostaglandin E2 synthesis in the clonal osteoblast-like cell line MC3T3-E1.
    Prostaglandins, leukotrienes, and essential fatty acids, 1997, Volume: 56, Issue:2

    Topics: Alendronate; Alkaline Phosphatase; Animals; Calcification, Physiologic; Calcium; Cell Line; Clodronic Acid; Culture Media; Dinoprostone; Diphosphonates; DNA; Glycerophosphates; Mice; Osteoblasts; Pamidronate

1997
Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1997, Volume: 12, Issue:9

    Topics: Adenosine Triphosphate; Alendronate; Analgesics, Non-Narcotic; Apoptosis; Cell Survival; Cells, Cultured; Clodronic Acid; Diphosphonates; Humans; Liposomes; Microscopy, Fluorescence

1997
Bisphosphonates inhibit IL-6 production by human osteoblast-like cells.
    Scandinavian journal of rheumatology, 1998, Volume: 27, Issue:1

    Topics: Alendronate; Analgesics, Non-Narcotic; Clodronic Acid; Etidronic Acid; Humans; Interleukin-1; Interleukin-6; Osteoblasts; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1998
Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1998, Volume: 13, Issue:4

    Topics: Alendronate; Animals; Apoptosis; Bone Resorption; Cells, Cultured; Clodronic Acid; Diphosphonates; Enzyme Inhibitors; Etidronic Acid; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Ibandronic Acid; Lovastatin; Macrophages; Mevalonic Acid; Mice; Osteoclasts; Protein Prenylation; Protein Processing, Post-Translational; ras Proteins; Risedronic Acid; Structure-Activity Relationship

1998
Skin reactions associated with bisphosphonates: a report of 3 cases and an approach to management.
    The Journal of allergy and clinical immunology, 1998, Volume: 102, Issue:4 Pt 1

    Topics: Adult; Alendronate; Antineoplastic Agents; Breast Neoplasms; Clodronic Acid; Diphosphonates; Drug Hypersensitivity; Etidronic Acid; Female; Humans; Middle Aged; Pamidronate; Skin Tests; Urticaria

1998
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.
    Proceedings of the National Academy of Sciences of the United States of America, 1999, Jan-05, Volume: 96, Issue:1

    Topics: Alendronate; Animals; Bone Resorption; Cell Differentiation; Cells, Cultured; Cholesterol; Clodronic Acid; Diterpenes; Enzyme Activation; Farnesol; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mevalonic Acid; Mice; Osteoclasts; Protein Kinases; Rabbits; Skull; Squalene

1999
Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 1999, Volume: 8, Issue:2

    Topics: Alendronate; Analgesics, Non-Narcotic; Animals; Arthritis, Rheumatoid; Cells, Cultured; Clodronic Acid; Cytokines; Diphosphonates; Drug Carriers; Electrophoresis, Polyacrylamide Gel; Liposomes; Macrophages; Mice; NF-kappa B; Nitric Oxide; Protein Biosynthesis; Transcription Factor AP-1

1999
Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase.
    The Journal of biological chemistry, 1999, Dec-03, Volume: 274, Issue:49

    Topics: Alendronate; Animals; Apoptosis; Calcium Channel Blockers; Caspase Inhibitors; Caspases; Clodronic Acid; Diphosphonates; Diterpenes; Enzyme Activation; Etidronic Acid; Macrophage Colony-Stimulating Factor; Male; MAP Kinase Kinase Kinases; Mevalonic Acid; Mice; Mice, Inbred BALB C; Osteoclasts; Protein Prenylation; Protein Serine-Threonine Kinases; Risedronic Acid; Signal Transduction; Staurosporine; Time Factors

1999
The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis.
    Arthritis and rheumatism, 2001, Volume: 44, Issue:9

    Topics: Adenosine Triphosphate; Alendronate; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Apoptosis; Bone Resorption; Capsules; Cells, Cultured; Clodronic Acid; Liposomes; Macrophages, Peritoneal; Osteoclasts; Protein Prenylation; Rabbits; rap1 GTP-Binding Proteins; Rats; Rats, Sprague-Dawley

2001
Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats.
    Acta orthopaedica Scandinavica, 2002, Volume: 73, Issue:1

    Topics: Alendronate; Animals; Bone Plates; Bone Resorption; Clodronic Acid; Diphosphonates; Disease Models, Animal; Dose-Response Relationship, Drug; Immunohistochemistry; Joint Instability; Male; Osseointegration; Preoperative Care; Probability; Prostheses and Implants; Rats; Rats, Wistar; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric; Tibia

2002
Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
    Cancer research, 2002, May-01, Volume: 62, Issue:9

    Topics: Alendronate; Antimetabolites; Bone Neoplasms; Cell Movement; Clodronic Acid; Dose-Response Relationship, Drug; Humans; Male; Mevalonic Acid; Neoplasm Invasiveness; Prostatic Neoplasms; Tumor Cells, Cultured

2002
Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2003, Volume: 18, Issue:2

    Topics: Adenosine Triphosphate; Alendronate; Animals; Apoptosis; Blotting, Western; Bone Resorption; Cell Line; Cell Membrane; Cell Nucleus; Cells, Cultured; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Ibandronic Acid; Macrophages; Mice; Microscopy, Fluorescence; Osteoclasts; Pinocytosis; Rabbits; Time Factors

2003
Effects of weekly administrations of alendronate+clodronate on young mouse tibia: localized action at the proximal growth plate.
    Calcified tissue international, 2004, Volume: 74, Issue:1

    Topics: Alendronate; Animals; Anti-Inflammatory Agents; Calcium; Clodronic Acid; Drug Administration Schedule; Drug Therapy, Combination; Growth Plate; Male; Mice; Mice, Inbred BALB C; Radiography; Tibia

2004
Effects of clodronate and alendronate on local and systemic changes in bone metabolism in rats with adjuvant arthritis.
    Inflammation, 2004, Volume: 28, Issue:1

    Topics: Alendronate; Animals; Arthritis, Experimental; Bone and Bones; Clodronic Acid; Male; Osteogenesis; Rats; Rats, Inbred Lew

2004
In vitro toxicity of bisphosphonates on human neuroblastoma cell lines.
    Anti-cancer drugs, 2004, Volume: 15, Issue:8

    Topics: Alendronate; Apoptosis; Cell Line, Tumor; Cell Proliferation; Clodronic Acid; Diphosphonates; Drug Screening Assays, Antitumor; Germany; Humans; Ibandronic Acid; Imidazoles; Neuroblastoma; Pamidronate; Time Factors; Zoledronic Acid

2004
Inhibition of inflammatory and bone-resorption-inhibitory effects of alendronate by etidronate.
    Calcified tissue international, 2005, Volume: 76, Issue:6

    Topics: Alendronate; Animals; Anti-Inflammatory Agents; Antimetabolites; Bone and Bones; Bone Resorption; Clodronic Acid; Drug Interactions; Drug Therapy, Combination; Etidronic Acid; Histidine Decarboxylase; Inflammation; Male; Mice; Mice, Inbred BALB C

2005
Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells.
    Molecular and cellular endocrinology, 2005, Aug-30, Volume: 240, Issue:1-2

    Topics: Alendronate; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Clodronic Acid; Diphosphonates; DNA-Binding Proteins; Female; Gene Expression; Humans; Pamidronate; Telomerase; Tumor Cells, Cultured

2005
Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay.
    Anti-cancer drugs, 2005, Volume: 16, Issue:9

    Topics: Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Alendronate; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Caspase 3; Caspase 7; Caspases; Cell Line, Tumor; Cell Survival; Cisplatin; Clodronic Acid; Diphosphonates; Energy Metabolism; Female; Humans; Imidazoles; Inhibitory Concentration 50; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured; Zoledronic Acid

2005
Comparative appraisal of clodronate, aspirin and dexamethasone as agents reducing alendronate-induced inflammation in a murine model.
    Basic & clinical pharmacology & toxicology, 2005, Volume: 97, Issue:4

    Topics: Alendronate; Animals; Anti-Inflammatory Agents; Aspirin; Bone Density Conservation Agents; Clodronic Acid; Dexamethasone; Histidine Decarboxylase; Inflammation; Interleukin-1; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Organ Size; Radiography; Sclerosis; Spleen; Tibia

2005
Mutual augmentation of the induction of the histamine-forming enzyme, histidine decarboxylase, between alendronate and immuno-stimulants (IL-1, TNF, and LPS), and its prevention by clodronate.
    Toxicology and applied pharmacology, 2006, May-15, Volume: 213, Issue:1

    Topics: Alendronate; Animals; Bone Density Conservation Agents; Clodronic Acid; Enzyme Induction; Female; Histidine Decarboxylase; Immunologic Factors; Interleukin-1; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Tumor Necrosis Factor-alpha

2006
Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis.
    Molecular pharmacology, 2006, Volume: 69, Issue:5

    Topics: Alendronate; Animals; Biological Transport; Calcium; Cell Line; Clodronic Acid; Cytosol; Egtazic Acid; Endocytosis; Flow Cytometry; Fluorescent Dyes; Kinetics; Macrophages; Mice; Microscopy, Confocal; Strontium

2006
Differential effects of bisphosphonates on breast cancer cell lines.
    Cancer letters, 2007, Feb-08, Volume: 246, Issue:1-2

    Topics: Alendronate; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Clodronic Acid; Cyclin D1; Diphosphonates; DNA Fragmentation; Etidronic Acid; Female; Flow Cytometry; Humans; Ibandronic Acid; Imidazoles; Pamidronate; Risedronic Acid; RNA, Messenger; Zoledronic Acid

2007
Histidine decarboxylase-stimulating and inflammatory effects of alendronate in mice: involvement of mevalonate pathway, TNFalpha, macrophages, and T-cells.
    International immunopharmacology, 2007, Volume: 7, Issue:2

    Topics: Alendronate; Animals; Bone Density Conservation Agents; Clodronic Acid; Female; Histidine Decarboxylase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-1alpha; Interleukin-1beta; Liposomes; Liver; Lung; Macrophages; Mevalonic Acid; Mice; Mice, Knockout; Peritoneal Cavity; Spleen; T-Lymphocytes; Tumor Necrosis Factor-alpha

2007
Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro.
    Aging clinical and experimental research, 2007, Volume: 19, Issue:2

    Topics: Alendronate; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Clodronic Acid; Diphosphonates; Female; Gene Expression Regulation, Neoplastic; Humans; Pamidronate; Telomerase

2007
Bisphosphonates: are they standard of care for the treatment of breast cancer?
    British journal of cancer, 2007, Jun-18, Volume: 96, Issue:12

    Topics: Alendronate; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Female; Humans; Randomized Controlled Trials as Topic

2007
Development and application of a high-performance liquid chromatography-mass spectrometry method to determine alendronate in human urine.
    Journal of chromatography. A, 2007, Aug-10, Volume: 1160, Issue:1-2

    Topics: Alendronate; Biological Availability; Chromatography, High Pressure Liquid; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Mass Spectrometry; Pamidronate; Reference Standards

2007
Antiangiogenic effects of bisphosphonates on laser-induced choroidal neovascularization in mice.
    Investigative ophthalmology & visual science, 2007, Volume: 48, Issue:12

    Topics: Alendronate; Angiogenesis Inhibitors; Animals; Cell Culture Techniques; Choroid; Choroidal Neovascularization; Clodronic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Fluorescein Angiography; Injections, Intraperitoneal; Integrin alphaV; Integrin beta1; Integrin beta3; Laser Coagulation; Male; Mice; Mice, Inbred C57BL; Pigment Epithelium of Eye; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A

2007
Alendronate augments interleukin-1beta release from macrophages infected with periodontal pathogenic bacteria through activation of caspase-1.
    Toxicology and applied pharmacology, 2009, Feb-15, Volume: 235, Issue:1

    Topics: Alendronate; Animals; Bacteroidaceae; Bone Density Conservation Agents; Caspase 1; Clodronic Acid; Dose-Response Relationship, Drug; Enzyme Activation; Interleukin-1beta; Macrophages; Mice; Periodontitis; Toll-Like Receptors

2009
RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro.
    Arthritis research & therapy, 2009, Volume: 11, Issue:2

    Topics: Alendronate; Animals; Apoptosis; bcl-X Protein; Blotting, Western; Clodronic Acid; Cyclin D1; Diphosphonates; In Vitro Techniques; Mice; Microscopy, Electron, Scanning; Myeloid Cell Leukemia Sequence 1 Protein; Osteoclasts; Proto-Oncogene Proteins c-bcl-2; Rabbits; RANK Ligand

2009
Rapid analysis of alkylphosphonate drugs by capillary zone electrophoresis using indirect ultraviolet detection.
    Journal of separation science, 2010, Volume: 33, Issue:2

    Topics: Alendronate; Benzoic Acid; Buffers; Clodronic Acid; Diphosphonates; Electrophoresis, Capillary; Fosfomycin; Hydrogen-Ion Concentration; Organophosphonates; Pharmaceutical Preparations; Phosphoric Acids; Reproducibility of Results; Solvents; Spectrophotometry, Ultraviolet; Temperature

2010
Pro-IL-1β accumulation in macrophages by alendronate and its prevention by clodronate.
    Toxicology letters, 2010, Nov-30, Volume: 199, Issue:2

    Topics: Alendronate; Animals; Bone Density Conservation Agents; Caspase 1; Cell Line; Clodronic Acid; Interleukin-1; Interleukin-1beta; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; Protein Precursors

2010
Fluorimetric quantification of clodronate and alendronate in aqueous samples and in serum.
    Talanta, 2011, Apr-15, Volume: 84, Issue:2

    Topics: Alendronate; Animals; Clodronic Acid; Fluorometry; Kinetics; Limit of Detection; Male; Rats; Rats, Wistar; Reproducibility of Results

2011
Osteoclasts derived from patients with neurofibromatosis 1 (NF1) display insensitivity to bisphosphonates in vitro.
    Bone, 2012, Volume: 50, Issue:3

    Topics: Adult; Aged; Alendronate; Biomarkers; Bone Density; Bone Resorption; Cells, Cultured; Clodronic Acid; Diphosphonates; Female; Humans; Imidazoles; Lumbar Vertebrae; Male; Middle Aged; Neurofibromatosis 1; Osteoclasts; Osteoporosis; Zoledronic Acid

2012
Cutting edge: nitrogen bisphosphonate-induced inflammation is dependent upon mast cells and IL-1.
    Journal of immunology (Baltimore, Md. : 1950), 2012, Apr-01, Volume: 188, Issue:7

    Topics: Alendronate; Animals; Chemotaxis; Clodronic Acid; Diphosphonates; Imidazoles; Interleukin-1alpha; Interleukin-1beta; Leukocytes; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Myeloid Differentiation Factor 88; Neutrophils; Pamidronate; Peritonitis; Receptors, Interleukin-1; Zoledronic Acid

2012
The effect of clodronate on a mevalonate kinase deficiency cellular model.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2012, Volume: 61, Issue:12

    Topics: Adolescent; Adult; Alendronate; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Cells, Cultured; Child; Clodronic Acid; Female; Humans; Inflammation; Lipopolysaccharides; Male; Mevalonate Kinase Deficiency; Mice; Models, Biological; Monocytes; Nitric Oxide; Young Adult

2012
Effects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk-hydroxyapatite films.
    Acta biomaterialia, 2014, Volume: 10, Issue:1

    Topics: Alendronate; Animals; Bombyx; Calcium; Clodronic Acid; Coculture Techniques; Diphosphonates; Durapatite; Humans; Osteoblasts; Osteoclasts; Silk; Surface Properties

2014
In vitro effect of bisphosphonates on oral keratinocytes and fibroblasts.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2014, Volume: 72, Issue:3

    Topics: Alendronate; Bone Density Conservation Agents; Cell Movement; Cell Proliferation; Cells, Cultured; Clodronic Acid; Coculture Techniques; Diphosphonates; Fetus; Fibroblasts; Foreskin; Humans; Imidazoles; Keratinocytes; Male; Mouth Mucosa; Zoledronic Acid

2014
Effect of bisphosphonates on the rapidly growing male murine skeleton.
    Endocrinology, 2014, Volume: 155, Issue:4

    Topics: Alendronate; Animals; Apoptosis; Biomechanical Phenomena; Bone and Bones; Bone Development; Bone Resorption; Chondrocytes; Clodronic Acid; Diphosphonates; Hypertrophy; Imidazoles; Male; Mice; Mice, Inbred C57BL; Pamidronate; Phenotype; X-Ray Microtomography; Zoledronic Acid

2014
High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2015, Volume: 43, Issue:3

    Topics: Alendronate; Apoptosis; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Clodronic Acid; Coloring Agents; Diphosphonates; Dose-Response Relationship, Drug; Flow Cytometry; G1 Phase; Humans; Ibandronic Acid; Necrosis; Osteoblasts; Pamidronate; Resting Phase, Cell Cycle; Spectrophotometry; Tetrazolium Salts; Thiazoles; Time Factors

2015
[Bisphosphonate use and related pharmaceutical issues II].
    Acta pharmaceutica Hungarica, 2016, Volume: 86, Issue:1

    Topics: Administration, Oral; Alendronate; Bone Density Conservation Agents; Bone Neoplasms; Clodronic Acid; Confounding Factors, Epidemiologic; Diphosphonates; Drug Costs; Drug Prescriptions; Drugs, Generic; Humans; Hungary; Ibandronic Acid; Imidazoles; National Health Programs; Osteoporosis; Pamidronate; Retrospective Studies; Risedronic Acid; Zoledronic Acid

2016
The role of monocyte subpopulations in vascular injury following partial and transient depletion.
    Drug delivery and translational research, 2018, Volume: 8, Issue:4

    Topics: Alendronate; Animals; Carotid Artery Injuries; Clodronic Acid; Coronary Restenosis; Liposomes; Male; Monocytes; Rats; Vascular System Injuries

2018
Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro.
    Clinical oral investigations, 2018, Volume: 22, Issue:7

    Topics: Administration, Oral; Alendronate; Apoptosis; Cell Movement; Cell Survival; Cells, Cultured; Clodronic Acid; Diphosphonates; Endothelial Cells; Fibroblasts; Humans; Ibandronic Acid; In Vitro Techniques; Infusions, Intravenous; Osteoblasts; Zoledronic Acid

2018
Bisphosphonate Modulation of the Gene Expression of Different Markers Involved in Osteoblast Physiology: Possible Implications in Bisphosphonate-Related Osteonecrosis of the Jaw.
    International journal of medical sciences, 2018, Volume: 15, Issue:4

    Topics: Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 7; Cell Differentiation; Cell Proliferation; Clodronic Acid; Diphosphonates; Gene Expression; Humans; Imidazoles; Osteoblasts; Osteoclasts; Primary Cell Culture; Transforming Growth Factor beta1; Zoledronic Acid

2018
Microcavity-Supported Lipid Bilayers; Evaluation of Drug-Lipid Membrane Interactions by Electrochemical Impedance and Fluorescence Correlation Spectroscopy.
    Langmuir : the ACS journal of surfaces and colloids, 2019, 06-18, Volume: 35, Issue:24

    Topics: Alendronate; Clodronic Acid; Diclofenac; Dielectric Spectroscopy; Electric Impedance; Ibuprofen; Levofloxacin; Lipid Bilayers; Pefloxacin; Rifampin; Spectrometry, Fluorescence

2019